Extensive apoptosis of bone marrow cells as evaluated by the in situ end-labelling (ISEL) technique may be the basis for ineffective haematopoiesis in patients with myelodysplastic syndromes.
- 24 April 2009
- journal article
- clinical trial
- Published by Wiley in European Journal of Haematology
- Vol. 62 (1) , 19-26
- https://doi.org/10.1111/j.1600-0609.1999.tb01109.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA.Journal of Histochemistry & Cytochemistry, 1993
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- Comparative evaluation of several DNA binding dyes in the detection of apoptosis‐associated chromatin degradation by flow cytometryCytometry, 1992
- The Origins of DNA Breaks: A Consequence of DNA Damage, DNA Repair, or Apoptosis?Cancer Investigation, 1992
- Rescue from programmed cell death in leukemic and normal myeloid cellsBlood, 1991
- Apoptosis is a Common Histopathological Finding in Myelodysplasia: the Correlate of Ineffective HaematopoiesisLeukemia & Lymphoma, 1990
- Myelodysplastic syndromes: Analysis of 131 cases according to the FAB classificationEuropean Journal of Haematology, 1987
- Cell Death: The Significance of ApoptosisPublished by Elsevier ,1980